Cargando…
Clinically Significant COVID-19 Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients
Autores principales: | Tsapepas, Demetra, Paget, Kathryn, Mohan, Sumit, Cohen, David J., Husain, S. Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the National Kidney Foundation, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129995/ https://www.ncbi.nlm.nih.gov/pubmed/34019949 http://dx.doi.org/10.1053/j.ajkd.2021.05.004 |
Ejemplares similares
-
Postvaccine Anti–SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients
por: Husain, Syed Ali, et al.
Publicado: (2021) -
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2021) -
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
por: Mamez, Anne-Claire, et al.
Publicado: (2021) -
Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients
por: Gavriilaki, Eleni, et al.
Publicado: (2022) -
Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients
por: Wu, Xi, et al.
Publicado: (2022)